Dr. Christina Morillo
Professor
Diagnostics have traditionally been the bottleneck in healthcare delivery. Patients wait days or weeks for results, often requiring multiple visits to healthcare facilities. This model is being fundamentally disrupted.
The Shift to Decentralisation
Point-of-care diagnostics represent one of the most exciting areas of healthcare innovation. From rapid COVID-19 tests to continuous glucose monitoring, we're seeing diagnostics move closer to where patients need them most.
The technology enabling this shift is remarkable. Microfluidics, biosensors, and AI-powered interpretation are making it possible to perform complex analyses in devices that fit in your pocket.
Key advantages of next-generation diagnostics:
- Faster results leading to quicker treatment decisions
- Reduced healthcare costs through fewer clinic visits
- Improved patient engagement and compliance
- Better data collection for population health insights
For investors, this space offers compelling opportunities. The companies that can combine technical innovation with regulatory savvy and market access will define the next decade of diagnostics.